{"ModuleTitle": "Company Description", "CompanyName": "Mylan N.V.", "Symbol": "MYL", "Address": "BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE, AL10 9UL, United Kingdom", "Phone": "44 0 1707 853 000", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "Europe", "CompanyDescription": "Mylan N.V. (the successor registrant to Mylan Inc.), along with its subsidiaries\r\n(collectively, the \"Company,\" \"Mylan,\" \"our\" or \"we\"), is a global\r\npharmaceutical company committed to setting new standards in healthcare and\r\nproviding 7 billion people access to high quality medicine. We offer a portfolio\r\nof more than 7,500 products, including prescription generic, branded generic,\r\nbrand-name drugs and over-the-counter (\"OTC\") remedies. We market our products\r\nin more than 165 countries and territories. As of December 31, 2019, our global\r\nworkforce totaled approximately 35,000 employees and external contractors. Some\r\nof our employees are unionized or part of works councils or trade unions.\r\n                      [[Image Removed: ourmissiona01.jpg]]\r\nOn July 29, 2019, the Company, Pfizer Inc.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f28%2f0001623613-20-000011.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Andrea B. Miller", "title": "Head-Global Research & Development"}, {"name": "Heather M. Bresch", "title": "Chief Executive Officer & Executive Director"}, {"name": "Kenneth Scott Parks", "title": "Chief Financial Officer"}], "Number_of_employees": ["5,000"], "Subsidiaries": ["Famy Care"]}